Gritgen Therapeutics Co., Ltd.

This study tests a single-dose gene therapy for Chinese adults with severe hemophilia A, a bleeding disorder. The treatment uses a harmless virus to deliver a gene that helps the liver produce a missing clotting protein. Seven participants are being monitored for safety and how w…